{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:42:18Z","timestamp":1793148138741,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,11,11]],"date-time":"2005-11-11T00:00:00Z","timestamp":1131667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00403-005-0617-1","type":"journal-article","created":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T23:51:33Z","timestamp":1131666693000},"page":"289-293","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of the association between null genotypes of glutathione-S-transferases and Behcet\u2019s disease"],"prefix":"10.1007","volume":"297","author":[{"given":"S.","family":"Uzuno\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Okudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"G\u00f6kbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130.","family":"Mevlito\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sar\u03b9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,11,11]]},"reference":[{"key":"617_CR1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.toxlet.2003.12.075","volume":"151","author":"AO Ada","year":"2004","unstructured":"Ada AO, Suzen SH, Iscan M (2004) Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish population. Toxicol Lett 151:311\u2013315","journal-title":"Toxicol Lett"},{"key":"617_CR2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/13102818.2001.10819131","volume":"15","author":"S Aras","year":"2001","unstructured":"Aras S, Baltaci V, Yildirim O, Savas I, Alpas I, Sen E (2001) Glutathione S-transferase M1 and T1 gene polymorphism in patients with lung cancer among Turkish population. Biotechnol Biotec Eq 15:54\u201361","journal-title":"Biotechnol Biotec Eq"},{"key":"617_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000077332","volume":"36","author":"E Aydin","year":"2004","unstructured":"Aydin E, Sogut S, Ozyurt H, Ozugurlu F, Akyol O (2004) Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behcet\u2019s disease with and without ocular disease. Ophthalmic Res 36:177\u2013182","journal-title":"Ophthalmic Res"},{"key":"617_CR4","first-page":"1152","volume":"105","author":"H Beh\u00e7et","year":"1937","unstructured":"Beh\u00e7et H (1937) Uber rezidivierende aphthose durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152\u20131157","journal-title":"Dermatol Wochenschr"},{"key":"617_CR5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1468-3083.2005.01075.x","volume":"19","author":"S Bekpinar","year":"2005","unstructured":"Bekpinar S, Kilic N, Unlucerci Y, Akdag-Kose A, Azizlerli G, Ozbek-Kir Z (2005) Evaluation of nitrosative and oxidative stress in Behcet\u2019s disease. J Eur Acad Dermatol Venereol 19:167\u2013171","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"617_CR6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00008571-199604000-00005","volume":"6","author":"CL Chen","year":"1996","unstructured":"Chen CL, Liu Q, Relling MV (1996) Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 6:187\u2013191","journal-title":"Pharmacogenetics"},{"key":"617_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0009-9120(94)90046-9","volume":"27","author":"P Dogan","year":"1994","unstructured":"Dogan P, Tanrikulu G, Soyuer U, Kose K (1994) Oxidative enzymes of polymorphonuclear leucocytes and plasma fibrinogen, ceruloplasmin, and copper levels in Behcet\u2019s disease. Clin Biochem 27:413\u2013418","journal-title":"Clin Biochem"},{"key":"617_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0027-5107(01)00209-3","volume":"482","author":"M Dusinska","year":"2001","unstructured":"Dusinska M, Ficek A, Horska A, Raslova K, Petrovska H, Vallova B, Drlickova M, Wood SG, Stupakova A, Gasparovic J (2001) Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans. Mutat Res-Fund Mol M 482:47\u201355","journal-title":"Mutat Res-Fund Mol M"},{"key":"617_CR9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000018029","volume":"197","author":"JP Freitas","year":"1998","unstructured":"Freitas JP, Filipe P, Yousefi A, Emerit I, Rodrigo FG (1998) Oxidative Stress in Adamantiades-Behcet\u2019s disease. Dermatology 197:343\u2013348","journal-title":"Dermatology"},{"key":"617_CR10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3349\/ymj.1997.38.6.423","volume":"38","author":"A Gurler","year":"1997","unstructured":"Gurler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behcet\u2019s disease: an analysis of 2147 patients. Yonsei Med J 38:423\u2013427","journal-title":"Yonsei Med J"},{"key":"617_CR11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/10715769900300851","volume":"31","author":"JD Hayes","year":"1999","unstructured":"Hayes JD, McLellan LI (1999) Glutathione and glutathione-dependent enzymes represent a coordinately regulated defense against oxidative stress. Free Radical Res 31:273\u2013300","journal-title":"Free Radical Res"},{"key":"617_CR12","unstructured":"International Study Group for Behcet\u2019s Disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080"},{"key":"617_CR13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0009-9120(02)00400-9","volume":"35","author":"I Kokcam","year":"2002","unstructured":"Kokcam I, Naziroglu M (2002) Effects of vitamin E supplementation on blood antioxidants levels in patients with Behcet\u2019s disease. Clin Biochem 35:633\u2013639","journal-title":"Clin Biochem"},{"key":"617_CR14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/bcr17","volume":"1","author":"S Lizard-Nacol","year":"1999","unstructured":"Lizard-Nacol S, Coudert B, Colosetti P, Riedinger JM, Fargeot P, Brunet-Lecomte P (1999) Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer. Breast Cancer Res 1:81\u201387","journal-title":"Breast Cancer Res"},{"key":"617_CR15","first-page":"229","volume":"10","author":"K Mitrunen","year":"2001","unstructured":"Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Komsa VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A, (2001) Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomar Prev 10:229\u2013236","journal-title":"Cancer Epidemiol Biomar Prev"},{"key":"617_CR16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3349\/ymj.2003.44.5.771","volume":"44","author":"T Noyan","year":"2003","unstructured":"Noyan T, Sahin I, Sekeroglu MR, Dulger H (2003) The serum vitamin C levels in Behcet\u2019s disease. Yonsei Med J 44:771\u2013778","journal-title":"Yonsei Med J"},{"key":"617_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/009841000157041","volume":"59","author":"I Onaran","year":"2000","unstructured":"Onaran I, Ozaydin A, Akbas F, Gultepe M, Tunckale A, Ulutin T (2000) Are individuals with glutathione S-transferase GST-T1 null genotype more susceptible to in vitro oxidative damage? J Toxicol Environ Health Part A 59:15\u201326","journal-title":"J Toxicol Environ Health Part A"},{"key":"617_CR18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1026750431055","volume":"16","author":"I Onaran","year":"2000","unstructured":"Onaran I, Ozaydin A, Ozdas SB, Ulutin T (2000) Inhibition of platelet function by GSTM1-null human peripheral lymphocytes exposed to benzo(a)pyrene-induced challenge. Cell Biol Toxicol 16:313\u2013323","journal-title":"Cell Biol Toxicol"},{"key":"617_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0009-9120(02)00290-4","volume":"35","author":"A Orem","year":"2002","unstructured":"Orem A, Yandi YE, Vanizor B, Cimsit G, Uydu HA, Malkoc M (2002) The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behcet\u2019s disease. Clin Biochem 35:217\u2013224","journal-title":"Clin Biochem"},{"key":"617_CR20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood-2002-12-3803","volume":"102","author":"S Rollinson","year":"2003","unstructured":"Rollinson S, Levene AP, Mensah FK, Rodam PL, Allan JM, Diss TC, Roman E, Jack A, MacLennan K, Dixon MF, Morgan GJ (2003) Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood 102:1007\u20131011","journal-title":"Blood"},{"key":"617_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1468-3083.2003.t01-1-00574.x","volume":"17","author":"B Sancak","year":"2003","unstructured":"Sancak B, Onder M, Oztas MO, Bukan N, Gurer MA (2003) Nitric oxide levels in Behcet\u2019s disease. J Eur Acad Dermatol Venereol 17:7\u20139","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"617_CR22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1067\/mcp.2000.104944","volume":"67","author":"T Simon","year":"2000","unstructured":"Simon T, Becquemont L, Mary-Krause M, de Waziers I, Beaune P, Funck-Brentano C, Jaillon P (2000) Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity. Clin Pharmacol Ther 67:432\u2013437","journal-title":"Clin Pharmacol Ther"},{"key":"617_CR23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0378-4274(99)00230-1","volume":"112\u2013113","author":"RC Strange","year":"2000","unstructured":"Strange RC, Jones PW, Fryer AA (2000) Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 112\u2013113:357\u2013363","journal-title":"Toxicol Lett"},{"key":"617_CR24","first-page":"185","volume":"296","author":"U Tursen","year":"2004","unstructured":"Tursen U, Tamer L, Eskandari G, Kaya IT, Aras-Ates N, Ikizoglu G, Atik U (2004) Glutathione S-transferase polymorphisms in patients with Behcet\u2019s disease. Arch Dermatol Res 296:185\u2013187","journal-title":"Arch Dermatol Res"},{"key":"617_CR25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00008571-200307000-00005","volume":"13","author":"OL Hel Van der","year":"2003","unstructured":"Van der Hel OL, Peeters PH, Hein DW, Doll MA, Grobbee DE, Kromhout D, Bueno de Mesquita HB (2003) NAT2 slow acetylation and GST-M1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. Pharmacogenetics 13:399\u2013407","journal-title":"Pharmacogenetics"},{"key":"617_CR26","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1046\/j.1471-4159.2003.02276.x","volume":"88","author":"JF Wang","year":"2004","unstructured":"Wang JF, Shao L, Sun X, Young LT (2004) Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons. J Neurochem 88:1477\u20131484","journal-title":"J Neurochem"},{"key":"617_CR27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2004.06003.x","volume":"151","author":"C Yazici","year":"2004","unstructured":"Yazici C, Kose K, Calis M, Demir M, Kirnap M, Ates F (2004) Increased advanced oxidation protein products in Behcet\u2019s disease: a new activity marker? Brit J Dermatol 151:105\u2013111","journal-title":"Brit J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-005-0617-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-005-0617-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-005-0617-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:37:35Z","timestamp":1559065055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-005-0617-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,11]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1007\/s00403-005-0617-1","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,11]]}}}